UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (232) 232
Conference Proceeding (149) 149
Patent (41) 41
Dissertation (28) 28
Book Chapter (2) 2
Publication (2) 2
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (169) 169
life sciences & biomedicine (133) 133
humans (121) 121
oncology (99) 99
female (83) 83
male (77) 77
lung cancer (75) 75
middle aged (72) 72
aged (66) 66
lung neoplasms - genetics (61) 61
lung neoplasms - pathology (49) 49
adult (46) 46
lung neoplasms - drug therapy (45) 45
hardware (43) 43
aged, 80 and over (36) 36
mutation (34) 34
adenocarcinoma - genetics (32) 32
carcinoma, non-small-cell lung - drug therapy (32) 32
lung cancer, non-small cell (31) 31
computer architecture (30) 30
research (30) 30
respiratory system (28) 28
cancer (27) 27
analysis (26) 26
smoking (26) 26
adenocarcinoma (25) 25
digital signal processing (25) 25
carcinoma, non-small-cell lung - pathology (24) 24
image coding (24) 24
lung neoplasms - mortality (24) 24
video coding (24) 24
antineoplastic agents - therapeutic use (22) 22
prognosis (22) 22
technology (22) 22
carcinoma, non-small-cell lung - genetics (21) 21
cell line, tumor (21) 21
motion estimation (21) 21
mpeg 4 standard (21) 21
adenocarcinoma - pathology (20) 20
discrete wavelet transforms (20) 20
metastasis (20) 20
genetic aspects (19) 19
bandwidth (18) 18
cell biology (18) 18
neoplasm staging (18) 18
receptor, epidermal growth factor - genetics (18) 18
transform coding (18) 18
adenocarcinoma of lung (17) 17
calculating (17) 17
carcinoma, non-small-cell lung - mortality (17) 17
care and treatment (17) 17
chemotherapy (17) 17
computing (17) 17
counting (17) 17
decoding (17) 17
design engineering (17) 17
electricity (17) 17
health aspects (17) 17
lung neoplasms - metabolism (17) 17
physics (17) 17
polymorphism, single nucleotide (17) 17
risk factors (17) 17
treatment outcome (17) 17
block codes (16) 16
costs (16) 16
electric communication technique (16) 16
engineering (16) 16
engineering, electrical & electronic (16) 16
erbb receptors - genetics (16) 16
genetic predisposition to disease (16) 16
medicine (16) 16
pictorial communication, e.g. television (16) 16
retrospective studies (16) 16
apoptosis (15) 15
case-control studies (15) 15
epidermal growth factor (15) 15
non-small cell lung cancer (15) 15
throughput (15) 15
abridged index medicus (14) 14
adenocarcinoma - drug therapy (14) 14
animals (14) 14
disease-free survival (14) 14
general & internal medicine (14) 14
medical colleges (14) 14
research article (14) 14
studies (14) 14
algorithm design and analysis (13) 13
algorithms (13) 13
computer science (13) 13
encoding (13) 13
interpolation (13) 13
lung adenocarcinoma (13) 13
multidisciplinary sciences (13) 13
non-small cell lung carcinoma (13) 13
quinazolines - therapeutic use (13) 13
science & technology - other topics (13) 13
taiwan (13) 13
tumors (13) 13
gefitinib (12) 12
genome-wide association study (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 07/2013, Volume 14, Issue 8, pp. 777 - 786
Summary Background The results of FASTACT, a randomised, placebo-controlled, phase 2 study, showed that intercalated chemotherapy and erlotinib significantly... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Time Factors | DNA Mutational Analysis | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Genetic Predisposition to Disease | Lung Neoplasms - enzymology | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Administration, Intravenous | Phenotype | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Asia | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Care and treatment | Chemotherapy | Clinical trials | Lung cancer, Non-small cell | Antineoplastic agents | Tumors | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2018, Volume 379, Issue 21, pp. 2027 - 2039
In a randomized trial involving patients with ALK -rearranged lung cancer, brigatinib was associated with longer progression-free survival and more activity... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - chemistry | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Organophosphorus Compounds - adverse effects | Crizotinib - therapeutic use | Lung Neoplasms - chemistry | Anaplastic Lymphoma Kinase - analysis | Kaplan-Meier Estimate | Organophosphorus Compounds - therapeutic use | Crizotinib - adverse effects | Pyrimidines - therapeutic use | Progression-Free Survival | Pyrimidines - adverse effects | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Anaplastic Lymphoma Kinase - antagonists & inhibitors | Crizotinib | Cancer patients | Safety and security measures | Development and progression | Dosage and administration | Comparative analysis | Lung cancer, Non-small cell | Drug therapy | Health aspects | Nuclear magnetic resonance--NMR | Medical imaging | Statistical analysis | Lung cancer | Non-small cell lung carcinoma | Metastasis | Radiation therapy | Lymphoma | Cancer therapies | Chemotherapy | Technical communication | Mutation | Protein-tyrosine kinase | Drug dosages | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Nature communications, ISSN 2041-1723, 03/2014, Volume 5, Issue 1, pp. 3472 - 3472
Journal Article
by Garassino, Marina Chiara and Cho, Byoung-Chul and Kim, Joo-Hang and Mazières, Julien and Vansteenkiste, Johan and Lena, Hervé and Corral Jaime, Jesus and Gray, Jhanelle E and Powderly, John and Chouaid, Christos and Bidoli, Paolo and Wheatley-Price, Paul and Park, Keunchil and Soo, Ross A and Huang, Yifan and Wadsworth, Catherine and Dennis, Phillip A and Rizvi, Naiyer A and Paz-Ares Rodriguez, Luis and Novello, Silvia and Hiret, Sandrine and Schmid, Peter and Laack, Eckart and Califano, Raffaele and Maemondo, Makoto and Kim, Sang-We and Chaft, Jamie and Vicente Baz, David and Berghmans, Thierry and Kim, Dong-Wan and Surmont, Veerle and Reck, Martin and Han, Ji-Youn and Holgado Martin, Esther and Belda Iniesta, Cristobal and Oe, Yuichiro and Chella, Antonio and Chopra, Akhil and Robinet, Gilles and Soto Parra, Hector and Thomas, Michael and Cheema, Parneet and Katakami, Nobuyuki and Su, Wu-Chou and Kim, Young-Chul and Wolf, Juergen and Lee, Jong-Seok and Saka, Hideo and Milella, Michele and Ramos Garcia, Inmaculada and Sibille, Anne and Yokoi, Takashi and Kang, Eun Joo and Atagi, Shinji and Spaeth-Schwalbe, Ernst and Nishio, Makoto and Imamura, Fumio and Gabrail, Nashat and Veillon, Remi and Derijcke, Sofie and Maeda, Tadashi and Zylla, Dylan and Kubiak, Kendra and Santoro, Armando and Uy, Ma. Noemi and Lucien Geater, Sarayut and Italiano, Antoine and Kowalski, Dariusz and Barlesi, Fabrice and Chen, Yuh-Min and Spigel, David and Chewaskulyong, Busyamas and Garcia Gomez, Ramon and Alvarez Alvarez, Rosa and Yang, Chih-Hsin and Hsia, Te-Chun and Denis, Fabrice and Sakai, Hiroshi and Vincent, Mark and Goto, Koichi and Bosch-Barrera, Joaquim and Weiss, Glen and Canon, Jean-Luc and Scholz, Christian and Aglietta, Massimo and Kemmotsu, Hirotsugu and Azuma, Koichi and Bradbury, Penelope and Feld, Ronald and Chachoua, Abraham and Jassem, Jacek and Juergens, Rosalyn and Palmero Sanchez, Ramon and Malcolm, Albert and Vrindavanam, Nandagopal and Kubota, Kaoru and Waller, Cornelius and Waterhouse, David and Coudert, Bruno and Mark, Zsuzsanna and ... and ATLANTIC Investigators
The lancet oncology, ISSN 1470-2045, 04/2018, Volume 19, Issue 4, pp. 521 - 536
Journal Article